If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPYX Resources Regulatory News (PYX)

  • This share is currently suspended. It was suspended at a price of 0.258

Share Price Information for PYX Resources (PYX)

Share Price is delayed by 15 minutes
Get Live Data
0.258    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.19m
PYX Live PriceLast checked at - London Stock Exchange

Intraday PYX Resources Share Chart

Performance Rights

27 May 2022 07:00

RNS Number : 0540N
PYX Resources Limited
27 May 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS ANNOUNCEMENT WOULD BE UNLAWFUL. THE COMMUNICATION OF THIS ANNOUNCEMENT IS NOT BEING MADE, AND HAS NOT BEEN APPROVED, BY AN AUTHORISED PERSON FOR THE PURPOSES OF SECTION 21 OF THE UK FINANCIAL SERVICES AND MARKETS ACT 2000.

 

PYX Resources Limited / EPIC: PYX / Market: Standard / Sector: Mining

 

27 May 2022

 

PYX Resources Ltd

("PYX" or the "Company")

Issue of Performance Rights

 

PYX Resources Ltd (NSX: PYX | LSE: PYX) confirms the award of Performance Rights under the Company's Stock Incentive Plan to Mr Oliver Hasler, Chief Executive Officer, following the approval of shareholders at the Company's Annual General Meeting ('AGM') held on 18 May 2022.

Mr Hasler was granted a total of 10,500,000 Performance Rights convertible into a maximum of 10,500,000 Company shares at any time to 31 December 2024, subject to the achievement of the following milestones:

· 3,500,000 vesting on the Company share price reaching AUD2.50

· 3,500,000 vesting on the Company share price reaching AUD3.10

· 3,500,000 vesting on the Company share price reaching AUD3.70

Current Shares and Performance Rights Held by Directors:

Following the issuance, Mr Hasler will hold a total of 20,332,494 Performance Rights convertible into a maximum of 23,532,494 shares plus 11,965,373 shares.

Following the grant of the abovementioned Performance Rights, the Company's capital structure is as follows:

No.

Unrestricted ordinary shares in issue

436,699,484

Unlisted Options

2,620,931

Unlisted Performance Rights

20,412,494

Fully diluted share capital

459,732,909

 

 

*** ENDS ***

 

 

For more information:

PYX Resources Limited

Oliver B. Hasler, Chairman and Chief Executive Officer

T: +852 3519 2860

E: ir@pyxresources.com

VSA Capital Limited (Financial Adviser and Broker)

Andrew Raca (Corporate Finance)

Andrew Monk / David Scriven (Corporate Broking)

T: +44 (0)20 3005 5000

 

St Brides Partners Ltd (Financial PR)

Ana Ribeiro / Isabel de Salis / Oonagh Reidy / Isabelle Morris

E: pyx@stbridespartners.co.uk

 

 

 

About PYX Resources

PYX Resources Limited (NSX: PYX | LSE: PYX) is a producer of premium zircon dual listed on the National Stock Exchange of Australia and on the Main Market of the London Stock Exchange. PYX's key deposits, Mandiri and Tisma, are large-scale, near-surface open pit deposits both located in the alluvium-rich region of Central Kalimantan, Indonesia. PYX, whose Mandiri deposit has been in production since 2015, is the 2nd largest publicly traded producing mineral sands company by zircon resources globally. Determined to mine responsibly and invest in the wider communities where we operate, PYX is committed to fully developing its Mandiri and Tisma deposits, with the vision to consolidate the mineral sands resources in Kalimantan and explore and acquire mineral sands assets in Asia and beyond.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGUGDURSDDGDR
Date   Source Headline
27th Jun 20227:00 amRNSPYX Starts Production and Sales of Ilmenite
27th May 20227:00 amRNSPerformance Rights
18th May 202211:08 amRNSAmended Constitution
18th May 202211:03 amRNSResult of AGM
4th May 20224:41 pmRNSSecond Price Monitoring Extn
4th May 20224:35 pmRNSPrice Monitoring Extension
29th Apr 20224:41 pmRNSSecond Price Monitoring Extn
29th Apr 20224:36 pmRNSPrice Monitoring Extension
14th Apr 20229:05 amRNSNotice of Annual General Meeting
30th Mar 20227:03 amRNS63% of Local Employees Registered to Give Blood
29th Mar 20227:00 amRNSNotice of AGM
21st Mar 20227:11 amRNSApplication for Quotation of Additional Securities
21st Mar 20227:00 amRNSPYX Resources Increases Price for Premium Zircon
18th Mar 20227:00 amRNSPresentation of Full Year Results
16th Mar 20227:00 amRNSFinal Results
11th Mar 20228:30 amRNSShare Placement to US Institutional Investor
10th Mar 20227:00 amRNSNotice of Results
22nd Feb 20227:00 amRNSStrong Fundamentals to Accelerate Growth
18th Feb 20228:57 amRNSNew Corporate Presentation
12th Jan 20227:00 amRNSPYX Commences Production and Sales of Rutile
7th Jan 20228:49 amRNSExercise of Performance Rights
21st Dec 20217:00 amRNS2021 Investor Newsletter
1st Dec 20217:00 amRNSIncreases Production Capacity
26th Nov 20219:20 amRNSHolding(s) in Company
26th Nov 20219:20 amRNSHolding(s) in Company
23rd Nov 20217:00 amRNSCorporate Presentation & Investor Presentation
15th Nov 20217:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.